Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4

Oncotarget
Tao JiangYongqian Jia

Abstract

Epigenetic abnormalities play important roles in the pathogenesis of Hodgkin lymphoma (HL). Highly expressed class I histone acetyltransferase (HDAC) and hyper-methylation of the promoter region of tumor suppressor genes have been demonstrated in Hodgkin lymphoma. In this paper, we investigated the synergistic effects of combination treatment of chidamide, a selective HDAC inhibitor, and decitabine, a demethylation agent, for HL cell lines and explored a new strategy for treating HL. The apoptosis rates, cell cycle, mitochondrial transmembrane potentials, epigenetic changes and gene expression of HL cell lines treated with chidamide as a single agent and in combination with decitabine were tested. We found that chidamide inhibited the proliferation of HL cells through increased apoptosis. Interestingly, after combined with decitabine, the inhibition rate and apoptotic death in HL cells were significantly increased. Further studies demonstrated that when combined with decitabine the expression of acetylated histone H3 and H3K9 induced by chidamide in HL cells increased, and also the expression of tumor suppressor genes PU.1 and KLF4, which exert inhibition through apoptosis pathway. Therefore, we could come to a conclusion that ...Continue Reading

References

Jan 19, 2000·Nature·B D Strahl, C D Allis
Aug 19, 2007·Leukemia & Lymphoma·Elizabeth R PlimackJean-Pierre Issa
Sep 25, 2009·British Journal of Haematology·Annunziata GloghiniAnas Younes
Apr 27, 2010·Expert Opinion on Therapeutic Targets·Heiner AdamsAlexandar Tzankov
Oct 6, 2010·BMC Cancer·Sonja EberthHilmar Quentmeier
Dec 14, 2011·The New England Journal of Medicine·Ralph M MeyerUNKNOWN Eastern Cooperative Oncology Group
Jan 25, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bastian von TresckowAndreas Engert
Mar 6, 2012·The Oncologist·Radhakrishnan Ramchandren
Jan 24, 2013·The Journal of Pathology·Hanfeng GuanAlexey Ushmorov
Aug 1, 2015·Proteomics·Simone Sidoli, Benjamin A Garcia

❮ Previous
Next ❯

Methods Mentioned

BETA
histone acetylation
acetylation
ubiquitination
flow cytometry
PCR

Software Mentioned

Calcusyn
GraphPad Prism

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis